David Moatazedi is the former CEO of Evolus, Inc., a company focused on innovative aesthetic treatments. He earned his M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach. David led Evolus from May 2018 until early...

David Moatazedi is the former CEO of Evolus, Inc., a company focused on innovative aesthetic treatments. He earned his M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach. David led Evolus from May 2018 until early 2022, a period marked by significant growth and the development of the company's key products. In 2022, he received a compensation package of about $3.6 million, showcasing his alignment with company performance over time. Notably, David focused on cash compensation, which reflects a strategy to link executive pay directly to business success. Under his leadership, Evolus aimed to achieve ambitious financial and operational goals, driving the company's market presence. His experience and education set a solid foundation for innovative leadership in the business and aesthetic industries.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Evolus CEOs

E

David Moatazedi

CEO of Evolus

Education

M.B.A. from Pepperdine University and B.A. from California State University, Long Beach.

Field of Expertise

Sales & Marketing - Marketing

Sector of Economy

Healthcare

CEO of Evolus for

7 years 1 month (May 2018 - Present)

Previous Experience

Senior Vice President at Allergan, Inc.

Rivals

Competitors/colleagues of David Moatazedi

Holdings

See how much did David Moatazedi make over time.

Throughout his tenure at Evolus, David Moatazedi held a considerable amount of stock options and other forms of equity. In 2020, he saw a peak in his wealth from vested stock options, totaling approximately $1.2 million that year alone, emphasizing...

Throughout his tenure at Evolus, David Moatazedi held a considerable amount of stock options and other forms of equity. In 2020, he saw a peak in his wealth from vested stock options, totaling approximately $1.2 million that year alone, emphasizing his successful long-term incentive strategies. However, in 2022, his holdings dwindled as the focus turned towards cash compensation, reflecting a significant shift in his financial landscape. His commitment to the company was clear, as his ownership in Evolus shares represented a substantial portion of his total wealth, making him heavily invested in the company's success and performance metrics. This aligns with his compensation philosophy, which closely ties his financial incentives to the achievements of Evolus.

Total Stock Sold

$11.94M

EOLS

$11.94M

996,155 EOLS shares

What if they kept their stock?

If David Moatazedi didn't sell their stock, today they would have:
Extra EOLS996,155 shares worth $5.01M.
This is -58.02% and $6.93M less than what they got when they sold the stock.

Insider Trading

See recent insider trades of David Moatazedi.

EOLS

95,399 shares

EOLS

Mar 7, 2025

Received

EOLS

$113.97K

EOLS at $10.85/share

Dec 23, 2024

Sale

EOLS

$6.01M

EOLS at $12.75/share

Jun 4, 2024

Sale

EOLS

$204.13K

EOLS at $12.72/share

May 10, 2024

Sale

EOLS

$86.43K

EOLS at $13.86/share

Mar 27, 2024

Sale

EOLS

$1.34M

EOLS at $13.92/share

Mar 19, 2024

Sale

EOLS

$100.80K

EOLS at $13.08/share

Feb 21, 2024

Sale

EOLS

61,202 shares

EOLS

Feb 21, 2024

Received

EOLS

134,976 shares

EOLS

Feb 7, 2024

Received

EOLS

$818.81K

EOLS at $9.91/share

Dec 6, 2023

Sale

Compensation History

See how much did David Moatazedi make over time.

David Moatazedi's compensation details reveal a strategic approach centered on aligning his earnings with the company's performance. In 2022, he earned about $3.6 million, primarily driven by a salary of $596,875 and a significant amount from stock options. However, he received no bonuses or stock grants that year, which illustrates a shift towards cash rather than equity-based rewards. This change follows a previous year where his total compensation was notably lower at around $600,000. His 2020 compensation showcased both cash and stock worth over $1.4 million, emphasizing performance-based metrics that guided the payout structure. The focused strategy reflects a desire to retain talent while ensuring long-term financial health for Evolus.

Year

2022

Total Compensation

$1.79M

Salary

$596.88K

Board Justification

The compensation philosophy focuses on aligning executive compensation with company performance and market benchmarks to retain talent.

Bonus

$0.00

Board Justification

No bonus was awarded for the year 2022.

Other

$27.99K

Board Justification

Includes 401(k) matching contributions and insurance premiums.

Restricted Stock

$1.17M(0 RSU)

Board Justification

No stock awards vested in 2022.

Performance Metrics

Performance metrics include achieving financial targets and operational goals.

Other Evolus CEOs

Here are other CEOs of Evolus

Murphy Simhambhalta

Ex-CEO of Evolus

February 2018 - May 2018